GCM
Graham Capital Management Portfolio holdings
AUM
$3.28B
1-Year Return
7.17%
This Quarter Return
+4.86%
1 Year Return
+7.17%
3 Year Return
+21.95%
5 Year Return
+42.01%
10 Year Return
+61.8%
AUM
$3.14B
AUM Growth
-$192M
(-5.8%)
Cap. Flow
-$1.87B
Cap. Flow
% of AUM
-59.61%
Top 10 Holdings %
Top 10 Hldgs %
37.2%
Holding
1,410
New
426
Increased
206
Reduced
277
Closed
455
Top Buys
| 1 |
Ross Stores
ROST
|
$14.7M |
| 2 |
XYZ
Block, Inc.
XYZ
|
$13.9M |
| 3 |
Southern Company
SO
|
$13.4M |
| 4 |
Rivian
RIVN
|
$10.9M |
| 5 |
HES
Hess
HES
|
$10.4M |
Top Sells
| 1 |
Broadcom
AVGO
|
$32.4M |
| 2 |
Mastercard
MA
|
$31.2M |
| 3 |
Chevron
CVX
|
$25.6M |
| 4 |
Cintas
CTAS
|
$25.4M |
| 5 |
Travelers Companies
TRV
|
$24.6M |
Sector Composition
| 1 | Consumer Discretionary | 9.87% |
| 2 | Technology | 9.7% |
| 3 | Financials | 6.67% |
| 4 | Industrials | 5.29% |
| 5 | Communication Services | 4.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
876
Ardagh Metal Packaging
AMBP
$2.12B
| $74.8K | ﹤0.01% |
+19,487
| New | +$74.8K |
|
877
Future Fuel
FF
$172M
| $74K | ﹤0.01% |
+12,167
| New | +$74K |
|
878
Alto Ingredients
ALTO
$89M
| $71.6K | ﹤0.01% |
+26,921
| New | +$71.6K |
|
879
PMV Pharmaceuticals
PMVP
$76.3M
| $71K | ﹤0.01% |
+22,915
| New | +$71K |
|
|
EXK
880
Endeavour Silver
EXK
$1.78B
| $70.4K | ﹤0.01% |
+35,746
| New | +$70.4K |
|
881
Heritage Insurance Holdings
HRTG
$759M
| $68.6K | ﹤0.01% |
+10,519
| New | +$68.6K |
|
882
Rekor Systems
REKR
$135M
| $66.6K | ﹤0.01% |
19,987
-2,419
| -11% | -$8.06K |
|
883
LivePerson
LPSN
$86.3M
| $66.2K | ﹤0.01% |
17,469
-11,784
| -40% | -$44.7K |
|
|
EGRX
884
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $64.7K | ﹤0.01% |
+12,373
| New | +$64.7K |
|
885
NatWest
NWG
$56.6B
| $63K | ﹤0.01% |
+11,186
| New | +$63K |
|
886
Babcock & Wilcox
BW
$221M
| $63K | ﹤0.01% |
43,126
+9,191
| +27% | +$13.4K |
|
887
Design Therapeutics
DSGN
$348M
| $59.8K | ﹤0.01% |
22,569
+719
| +3% | +$1.91K |
|
888
Rigel Pharmaceuticals
RIGL
$720M
| $57K | ﹤0.01% |
3,929
+921
| +31% | +$13.4K |
|
|
KLRS
889
Kalaris Therapeutics, Inc. Common Stock
KLRS
$87.2M
| $55.9K | ﹤0.01% |
3,576
+3,056
| +588% | +$47.8K |
|
890
Butterfly Network
BFLY
$385M
| $54.7K | ﹤0.01% |
+50,603
| New | +$54.7K |
|
|
ALLK
891
DELISTED
Allakos
ALLK
| $54.4K | ﹤0.01% |
+19,913
| New | +$54.4K |
|
892
Erasca
ERAS
$420M
| $53.2K | ﹤0.01% |
24,955
-6,274
| -20% | -$13.4K |
|
893
Blink Charging
BLNK
$117M
| $50.9K | ﹤0.01% |
+15,000
| New | +$50.9K |
|
894
Taysha Gene Therapies
TSHA
$889M
| $50.4K | ﹤0.01% |
+28,477
| New | +$50.4K |
|
895
Lyell Immunopharma
LYEL
$225M
| $50.2K | ﹤0.01% |
+1,293
| New | +$50.2K |
|
|
CTEV
896
Claritev Corporation
CTEV
$1.11B
| $47.2K | ﹤0.01% |
+820
| New | +$47.2K |
|
897
Kodiak Sciences
KOD
$452M
| $43.6K | ﹤0.01% |
+14,333
| New | +$43.6K |
|
898
BridgeBio Pharma
BBIO
$9.91B
| $43.6K | ﹤0.01% |
+1,079
| New | +$43.6K |
|
|
BHR
899
Braemar Hotels & Resorts
BHR
$201M
| $40K | ﹤0.01% |
16,011
+5,242
| +49% | +$13.1K |
|
|
AMRN
900
Amarin Corp
AMRN
$311M
| $35.2K | ﹤0.01% |
2,022
+1,479
| +272% | +$25.7K |
|